Literature screening is an essential process in the field of Pharmacovigilance (PV), as it facilitates the identification of relevant information regarding the safety and efficacy of medicinal products. Artificial intelligence (AI) integrates advanced technology and machine learning techniques in PV literature searches, thereby accelerating the data collection process and allowing the analysis and interpretation of large volumes of information with unprecedented accuracy.
Have look at the poster that ASPHALION experts Sonia López and Laura Eder prepared for the World Drug Safety Congress 2024 about “AI in PV: transforming literature searches with advanced technologies”.
For further information, feel free to contact us at: [email protected]
